1. Home
  2. KE vs ESPR Comparison

KE vs ESPR Comparison

Compare KE & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KE
  • ESPR
  • Stock Information
  • Founded
  • KE 1961
  • ESPR 2008
  • Country
  • KE United States
  • ESPR United States
  • Employees
  • KE N/A
  • ESPR N/A
  • Industry
  • KE Electrical Products
  • ESPR Biotechnology: Pharmaceutical Preparations
  • Sector
  • KE Technology
  • ESPR Health Care
  • Exchange
  • KE Nasdaq
  • ESPR Nasdaq
  • Market Cap
  • KE 467.2M
  • ESPR 410.2M
  • IPO Year
  • KE N/A
  • ESPR 2013
  • Fundamental
  • Price
  • KE $19.17
  • ESPR $2.21
  • Analyst Decision
  • KE Buy
  • ESPR Buy
  • Analyst Count
  • KE 5
  • ESPR 5
  • Target Price
  • KE $22.60
  • ESPR $5.13
  • AVG Volume (30 Days)
  • KE 117.3K
  • ESPR 4.6M
  • Earning Date
  • KE 02-03-2025
  • ESPR 02-25-2025
  • Dividend Yield
  • KE N/A
  • ESPR N/A
  • EPS Growth
  • KE N/A
  • ESPR N/A
  • EPS
  • KE 0.50
  • ESPR N/A
  • Revenue
  • KE $1,650,685,000.00
  • ESPR $295,451,000.00
  • Revenue This Year
  • KE N/A
  • ESPR $186.88
  • Revenue Next Year
  • KE $3.66
  • ESPR $22.46
  • P/E Ratio
  • KE $38.30
  • ESPR N/A
  • Revenue Growth
  • KE N/A
  • ESPR 187.12
  • 52 Week Low
  • KE $16.64
  • ESPR $1.58
  • 52 Week High
  • KE $25.22
  • ESPR $3.94
  • Technical
  • Relative Strength Index (RSI)
  • KE 55.89
  • ESPR 44.94
  • Support Level
  • KE $17.69
  • ESPR $2.05
  • Resistance Level
  • KE $19.20
  • ESPR $2.40
  • Average True Range (ATR)
  • KE 0.56
  • ESPR 0.14
  • MACD
  • KE 0.08
  • ESPR 0.01
  • Stochastic Oscillator
  • KE 80.87
  • ESPR 45.71

About KE Kimball Electronics Inc.

Kimball Electronics Inc is a contract electronic manufacturing services company. The company is engaged in producing durable electronics for the automotive, medical, industrial, and public safety end markets. The company's engineering, manufacturing, and supply chain services utilize common production and support capabilities. It is also engaged in producing safety-critical electronic assemblies for its automotive customers. Geographically, it has business units located in the United States, China, Mexico, Poland, Romania, and Thailand. The company derives maximum revenue from Mexico.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: